Intra-Arterial Chemotherapy as Primary Therapy for Retinoblastoma in Infants Less than 3 Months of Age: A Series of 10 Case-Studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intra-Arterial Chemotherapy as Primary Therapy for Retinoblastoma in Infants Less than 3 Months of Age: A Series of 10 Case-Studies

Published:2016-08-09 Issue:8 Volume:11 Page:e0160873
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chen Miaojuan,Zhao Junyang,Xia Jiejun,Liu Zhenyin,Jiang Hua,Shen Gang,Li Haibo,Jiang Yizhou,Zhang Jing

Funder

Natural Science Foundation of Guangdong Province

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma;H Dimaras;Hum Mol Genet,2008

2. Retinoblastoma;H Dimaras;Lancet,2012

3. Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation;MP Chan;Br J Ophthalmol,2009

4. Snare technique for enucleation of eyes with advanced retinoblastoma;V Schiedler;Arch Ophthalmol,2007

5. Conservative treatment modalities in retinoblastoma;B Chawla;Indian J Ophthalmol,2013

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retinoblastoma: An update on genetic origin, classification, conventional to next-generation treatment strategies;Heliyon;2024-06

2. Revisión actualizada de la quimioterapia intraarterial para el retinoblastoma;Radiología;2024-05

3. A meta-analysis of the efficacy of intra-arterial chemotherapy for the management of retinoblastoma patients;Advances in Clinical and Experimental Medicine;2023-07-24

4. Spotlight on Targeted Chemotherapy in Retinoblastoma: Safety, Efficacy, and Patient Outcomes;OncoTargets and Therapy;2022-12

5. Intra-arterial chemotherapy for retinoblastoma: Our first experience in Indonesia;Radiology Case Reports;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3